Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs

Journal of Pharmaceutical Sciences

Volumn 88, Issue 5, 1999, Pages 561-567

  Bonina, Francesco Paolo ^a   Arenare, Loredana ^b   Palagiano, Francesco ^b   Saija, Antonella ^c   Nava, Felice ^d   Trombetta, Domenico ^c   De Caprariis, Paolo ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Istituto di Matematica   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; NIPECOTIC ACID; PRODRUG;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG POTENCY; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; FEMALE; MALE; MOUSE; NONHUMAN;

EID: 0032897670     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980302n     Document Type: Article

References (31)

1. Greig, N. H. Drug entry into the brain and its pharmacological manipulation. In: Physiology and Pharmacology of the Blood-Brain Barrier. Bradbury, M. W. B., Ed.; Springer-Verlag: New York, 1992; pp 487-524.
2. Robinson, P. J.; Rapoport, S. I. Transport of drugs. In: Physiology and Pharmacology of the Blood-Brain Barrier. Bradbury, M. W. B., Ed.; Springer-Verlag: New York, 1992; pp 279-300.
3. Greenwood, J. Experimental manipulation of the blood-brain and blood-retinal barriers. In: Physiology and Pharmacology of the Blood-Brain Barrier. Bradbury, M. W. B., Ed.; Springer-Verlag: New York, 1992; pp 459-486.
4. Walker, I.; Nicholls, D.; Irwin, W. J.; Freeman, S. Drug delivery via active transport at the blood-brain barrier: affinity of a prodrug of phosphonoformate for the large amino acid transporter. Int. J. Pharm. 1994, 104, 157-167.
5. Namane, A.; Gouyette, C.; Fillion, M.; Fillion, G.; Huynh-Dinh, T. Improved brain delivery of AZT using a glycosyl phosphotriester prodrug, J. Med. Chem. 1992, 35, 3039-3044.
6. Mizuma, T.; Ohta, K.; Hayashi, M.; Awazu, S. Intestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly adsorbable drugs, Biochem. Pharmacol. 1992, 43, 2037-2039.
7. Mizuma, T.; Ohta, K.; Hayashi, M.; Awazu, S. Comparative study of active absorption by the intestine and disposition of anomers of sugar-conjugated compounds. Biochem. Pharmacol. 1993, 45, 1520-1523.
8. Mizuma, T.; Ohta, K.; Awazu, S. The beta-anomeric and glucose preferences of glucose transport carrier for intestinal active absorption of monosaccharide conjugates. Biochim. Biophys. Acta 1994, 1200, 117-122.
9. Bonina, F. P.; Lanza, M.; Montenegro, L.; Salerno, L.; Smeriglio, P.; Trombetta, D.; Saija, A. Transport of alpha-tocopherol and its derivatives through erytrocyte membranes. Pharm. Res. 1996, 13, 1342-1346.
10. Krogsgaard-Larsen, P.; Johnston, G. A. R. Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J. Neurochem. 1975, 25, 797-802.
11. Meldrum, B. S.; Croucher, M. J.; Krogsgaard-Larsen, P. GABA-uptake inhibitors as anticonvulsant agents. In: Problems in GABA Research; Okada, Y.; Roberts, E., Eds.; Exerpta Medica: Amsterdam, 1982; pp 182-191.
12. Horton, R. W.; Collins, J. F.; Anlezark, G. M.; Meldrum, B. S. Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA. Eur. J. Pharmacol. 1979, 59, 75-83.
13. Hinko, C. N.; Seibert, K.; Crider, A. M. Anticonvulsant activity of the nipecotic acid ester, (±)-m-nitrophenyl-3-piperidinecarboxylate, Neuropharmacology 1984, 23, 1009-1014.
14. Hinko, C. N.; Crider, A. M.; Wood, J. D. A comparison of prodrug esters of nipecotic acid. Neuropharmacology 1988, 27(5), 475-483.
15. Dhar, T. G.; Borden, L. A.; Tyagarajan, S.; Smith, K E.; Branchek, T. A.; Weinshank, R. L.; Gluchowski, C. Design, synthesis and evaluation of substituted triaryl nipecptic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human Gaba transporter GAT.3. J. Med. Chem. 1994, 37-(15), 2334-2342.
16. Chapman, A. G.; Croucher, M. J.; Meldrum, B. S. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneim.-Forsch. / Drug Res. 1984, 34, 1261-1264.
17. Seyfried, T. N.; Glaser, G. H. A review of mouse mutants as genetic models of epilepsy. Epilepsia 1986, 26, 143-150.
18. Bonina, F. P.; Montenegro, L.; Guerrera, F. Naproxen 1-alkylazacicloalkan-2-one esters as dermal prodrugs: in vitro evaluation. Int. J. Pharm. 1993, 100, 99-105.
19. Fischer, R. S. Animal models of the epilepsies. Brain Res. Rev. 1989, 14, 245-278.
20. Horton, R. W.; Prestwich, S. A.; Meldrum, B. S. Gamma-aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice. J. Neurochem, 1982, 39, 864-870.
21. De Sarro, G. B.; Chimirri, A.; De Sarro, A.; Gitto, R.; Grasso, S.; Giusti, P.; Chapman. A. G. GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice. Eur. J. Pharmacol. 1996, 294, 411-422.
22. Suzdak, P. D.; Jansen, J. A. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 1995, 36, 612-626.
23. Smith, Q. R.; Momma, S.; Aoyagi, M.; Rapoport, S. I. Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem. 1987, 49, 1651-1658.
24. Reichel, A.; Begley, D. C.; Ermisch, A. Arginine vasopressin reduces the blood-brain transfer of L-tyrosine and L-valine: further evidence of the effect of the peptide on the L-system transporter at the blood-brain barrier. Brain Res. 1996, 713, 232-239.
25. Stark, H.; Van Bree, J. B.; de Boer, A. G.; Jaehde, U.; Breimer, D. D. In vitro penetration of des-tyrosine 1-D-phenylalanina-3-beta-casomorphin across the blood-brain barrier. Peptides 1992, 13, P47-51.
26. Dalby, N. O.; Nielsen, E. B. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res. 1997, 28, 63-72.
27. Crider, A. M.; Tita, T. T.; Wood, J. D.; Hinko, C. N. Esters of nipecotic and isonipecotic acids as potential anticonvulsants. J. Pharm. Sci. 1982, 71, 1214-1219.
28. Nassereddine-Sebaei, M.; Crider, A. M.; Carrol, R. T.; Hinko, C. N. Determination of m-nitrophenol and nipecotic acid in mouse tissues by high-performance liquid chromatography after administration of the anticonvulsivant m-nitrophenyl-3-piperidinecarboxylate hydro-chloride. J. Pharm. Sci. 1993, 82, 39-43.
29. Falch, E.; Krogsgaard-Larsen, P. Esters of isoguvacine as potential prodrugs. J. Med. Chem. 1981, 24, 285-289.
30. Fuglsang, A.; Lomholt, M.; Gjedde, A. Blood-brain transfer of glucose and glucose analogues in newborn rats. J. Neurochem. 1986, 46, 1417-1428.
31. Takakura, Y.; Hashida, M. Macromolecular carrier systems for targeted drug delivery: pharmacokinetics considerations on biodistribution. Pharm. Res. 1996, 13, 820-831.